Olsalazine sodium

奥沙拉秦钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOlsalazine sodium
Drug Alias Name奥沙拉秦Azodisal disodium奥柳氮钠olsalazinaolsalazine +[14
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsColitis, UlcerativeSpondylitis, Ankylosing
Global Approved IndicationsColitis, Ulcerative
Approved Indications in ChinaColitis, Ulcerative
Original Approved Country/TerritoryUnited States
Original Approved Date1990/07/31
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMeda Ab
China Registration ClassN/A

Develop Information

Active IndicationsColitis, Ulcerative
Inactive IndicationsSpondylitis, Ankylosing

Other Information

ATC CodeA07EC03